Mechanisms of Ovarian Cancer Metastasis: Biochemical Pathways

被引:52
作者
Nakayama, Kentaro [1 ]
Nakayama, Naomi [2 ]
Katagiri, Hiroshi [1 ]
Miyazaki, Kohji [1 ]
机构
[1] Shimane Univ, Dept Obstet & Gynecol, Sch Med, Izumo, Shimane 6938501, Japan
[2] Shimane Univ, Dept Biochem, Sch Med, Izumo, Shimane 6938501, Japan
关键词
cancer; metastasis suppressor gene; EMT; tumor microenvironment; MESENCHYMAL STEM-CELLS; SUPPRESSOR GENE; CARCINOMA-CELLS; E-CADHERIN; FAVORABLE PROGNOSIS; UP-REGULATION; TUMOR-CELLS; IN-VITRO; EXPRESSION; PROTEIN;
D O I
10.3390/ijms130911705
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Ovarian cancer is the most lethal gynecologic malignancy. Despite advances in chemotherapy, the five-year survival rate of advanced ovarian cancer patients with peritoneal metastasis remains around 30%. The most significant prognostic factor is stage, and most patients present at an advanced stage with peritoneal dissemination. There is often no clearly identifiable precursor lesion; therefore, the events leading to metastatic disease are poorly understood. This article reviews metastatic suppressor genes, the epithelial-mesenchymal transition (EMT), and the tumor microenvironment as they relate to ovarian cancer metastasis. Additionally, novel chemotherapeutic agents targeting the metastasis-related biochemical pathways are discussed.
引用
收藏
页码:11705 / 11717
页数:13
相关论文
共 68 条
[1]
CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]
New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: Outside-in signaling and relationship to tumor progression [J].
Bauvois, Brigitte .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1825 (01) :29-36
[3]
Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[4]
Birner P, 2001, CLIN CANCER RES, V7, P1661
[5]
Opinion - Migrating cancer stem cells - an integrated concept of malignant tumour progression [J].
Brabletz, T ;
Jung, A ;
Spaderna, S ;
Hlubek, F ;
Kirchner, T .
NATURE REVIEWS CANCER, 2005, 5 (09) :744-749
[6]
Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness [J].
Cai, Jing ;
Tang, Huijuan ;
Xu, Linjuan ;
Wang, Xiaoyi ;
Yang, Chun ;
Ruan, Shasha ;
Guo, Jianfeng ;
Hu, Sha ;
Wang, Zehua .
CARCINOGENESIS, 2012, 33 (01) :20-29
[7]
CANNISTRA SA, 1993, CANCER RES, V53, P3830
[8]
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers [J].
Casey, RC ;
Koch, KA ;
Oegema, TR ;
Skubitz, KM ;
Pambuccian, S ;
Grindle, SM ;
Skubitz, APN .
CLINICAL & EXPERIMENTAL METASTASIS, 2003, 20 (04) :343-356
[9]
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers [J].
Cheng, KW ;
Lahad, JP ;
Kuo, WL ;
Lapuk, A ;
Yamada, K ;
Auersperg, N ;
Liu, JS ;
Smith-McCune, K ;
Lu, KH ;
Fishman, D ;
Gray, JW ;
Mills, GB .
NATURE MEDICINE, 2004, 10 (11) :1251-1256
[10]
Ovarian Cancer [J].
Cho, Kathleen R. ;
Shih, Ie-Ming .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :287-313